NCT00082316View on ClinicalTrials.gov

Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Herpes ZosterNeuralgiaPainHIV InfectionsPeripheral Nervous System DiseasesDiabetic NeuropathiesDiabetes MellitusPolyneuropathies
Interventions
DRUG

Capsaicin Dermal Patch

Trial Locations (17)

16635

NeurogesX Investigational Site, Duncansville

27408

NeurogesX Investigational Site, Greensboro

33161

NeurogesX Investigational Site, North Miami

33324

NeurogesX Investigational Site, Plantation

33765

NeurogesX Investigational Site, Clearwater

34652

NeurogesX Investigational Site, New Port Richey

35801

NeurogesX Investigational Site, Huntsville

36608

NeurogesX Investigational Site, Mobile

50265

NeurogesX Investigational Site, West Des Moines

63108

NeurogesX Investigational Site, St Louis

78229

NeurogesX Investigational Site, San Antonio

80209

NeurogesX Investigational Site, Denver

84106

NeurogesX Investigational Site, Salt Lake City

85023

NeurogesX Investigational Site, Phoenix

92708

NeurogesX Investigational Site, Fountain Valley

95032

NeurogesX Investigational Site, Los Gatos

02481-2106

NeurogesX Investigational Site, Wellesley Hills

Sponsors

Lead Sponsor

NeurogesX
All Listed Sponsors
lead

NeurogesX

INDUSTRY

NCT00082316 - Tolerability of Three Local Anesthetic Formulations in Conjunction With NGX-4010 for the Treatment of Neuropathic Pain | Biotech Hunter | Biotech Hunter